Erythrocyte ion concentrations and Ca-ATPase activity; Platelet free Ca and pH; Essential Hypertension; Chronic renal failure; Antihypertensive treatment; Hemodialysis
Abstract :
[en] The aim of this study was to test basal and after treatment erythrocyte sodium and calcium concentrations, and calcium-ATPase activity and platelet cytosolic free calcium and pH in 20 normotensive controls, 20 hemodialysis-dependent chronic renal failure patients and in 18 essential hypertensives. Prior to treatment, essential hypertensive and uremic patients presented similar higher platelet calcium concentrations and lower pH than the normotensive control group. The erythrocyte sodium, calcium, and magnesium concentrations were only significantly elevated in chronic renal failure, with a significant decrease in the calcium-ATPase activity in the latter population. Hemodialysis partially reversed these intracellular ionic abnormalities with normalization of platelet pH. Significant correlations have been noted between weight loss and decreases in platelet calcium concentration (r = 0.60, p < 0.01) or in erythrocyte sodium (r = 0.50, p < 0.05). The systolic blood pressure decrease was only correlated to the increase in calcium-ATPase activity (r = 0.57, p < 0.05). Antihypertensive treatment (captopril and nifedipine) only tended to normalize the intracellular calcium concentration with correlation between the decrease of the latter and blood pressure decrease (r = 0.64 for the systolic blood pressure and 0.68 for the diastolic blood pressure, p < 0.01). Thus, in essential hypertension and in uremia, some cellular ionic abnormalities exist in platelets in baseline condition. Moreover, in uremia, erythrocyte presents abnormal ionic pattern. Some, but not all of these abnormalities could be corrected by treatment affecting blood pressure (cellular calcium) in essential hypertension or by hemodialysis (cellular sodium, calcium, and pH). In the latter treatment, the changes are linked to extracellular fluid modification. In essential hypertension, the intracellular calcium reduction was linked to blood pressure decrease.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
Aviv A. (1988) Prospective review, the link between cytosolic Ca and the Na-H antiport: A unifying factor for essential hypertension. J. Hypertension 6:685-691.
Graves S.W., Brown B., Valdes R. (1983) An endogenous digoxin-like substance in patient with renal impairement. Ann. Intern. Med. 99:604-608.
Boero R., Guarena C., Berto I.M., Deabate M.C., Rosati C., Quarello F., Picolli G. (1988) Erythrocyte Na-K pump activity and arterial hypertension in uremic dialysed patients. Kidney Int. 34:691-696.
Gafter U., Malachi T., Barak H., Djaldetti M., Levy J. (1989) Red blood cell calcium homeostasis in patients with end-stage renal disease. J. Lab. Clin. Med. 114:222-231.
Cha Y.N., Shin B.C., Lee K.S. (1971) Active uptake of Ca and Ca-activated Mg ATPase in Red cell membrane fragments. J. Gen. Physiol. 57:2092-2115.
Oshima T., Young E.W., Bukoski R.D., MaCArron D.A. (1990) Abnormal calcium handling by platelets of spontaneously hypertensive rats. Hypertension 15:606-611.
Pollock W.K., Rink T.J., Irvine R.F. (1986) Liberation of [H3] arachidonic acid and changes in cytosolic free calcium in fura-2-loaded human platelets stimulated by ionomycin and collagen. Biochem. J. 235:869-877.
Rink R., Tsien R., Pozzan T. (1982) Cytoplasmic pH and free Mg in lymphocytes. J. Cel. Biol. 95:189-196.
Astarie C., David-Dufilho M., Devynck M.A. (1990) Direct characterization of the Na/H exchange in human platelets. F.E.B.S. Letters 277:235-238.
Hilton P.J. (1986) Cellular sodium transport in essential hypertension. N. Engl. J. Med. 314:222-229.
Bramley P., Paulin J., Millar J. (1986) Intracellular cations and transmembrane cation transport in essential hypertension: The importance of controlled clinical observations. J. Hypertension 4:589-596.
Lijnen P., Groeseneken D., Laermans M., Lommelen G., Piccart Y., Amery A. (1984) Methodological assesment of assays for intracellular concentration and transmembrane fluxes of sodium and potassium in erythrocytes of man. Meth. and Find. Clin. Pharmacol. 6:293-301.
Simon G., Conklin D. (1986) Vivo erythrocyte sodium concentration in human hypertension is reduced, not increased. J. Hypertension 4:71-75.
Erne P., Bolli P., Burgisser E., Buhler F. (1984) Correlation of platelet calcium with blood pressure. Effect of antihypertensive therapy. N. Engl. J. Med. 310:1084-1088.
Lindner A., Kenny M., Meacham A.J. (1987) Effects of a circulating factor in patients with essential hypertension on intracellular free calcium in normal platelets. N. Engl. J. Med. 316:509-513.
Pang P.T., Lewanczuk R.Z. (1989) Parathyroid origin of a new circulating hypertensive factor in spontaneously hypertensive rats. Am. J. Hypertension 2:898-902.
Weber M.A., Weiler E., Gonick H.C., Prins B.A., Purdy R.E. (1989) Effects of a human-derived sodium transport on in vivo vascular reactivity. Am. J. Hypertension 2:754-761.
Carafoli E., Zurini M. (1982) The Ca-pumping ATPase of plasma membranes purification, reconstitution and properties, Biochim. Biophys. Acta 683:279-301.
Postnov Y.V., Orlov S.N., Reznikova M.B., Rjazhsky G.G., Pokudin N.I. (1984) Calmodulin distribution and Ca-transport in the erythrocytes of patients with essential hypertension. Clin. Sci. 66:459-463.
Devynck M.A., Pernollet M.G., Nunez A.M., Meyer P. (1981) Analysis of calcium handling in erythrocyte membranes of genetically hypertensive rats. Hypertension 3:397-403.
Astarie C., Levenson J., Simon A., Meyer P., Devynck M.A. (1989) Platelet cytosolic proton and free calcium concentrations in essential hypertension. J. Hypertension 7:485-491.
Ng L.L., Dudley C., Bomford J., Hawley D. (1989) Leukocyte intracellular pH and Na/H antiport activity in human hypertension. J. Hypertension 7:471-475.
Weder A.B., Bahodosingh S.E., Neagos G.R. (1989) Platelet intracellular pH in essential hypertensives and normotensives. J. Hypertension 7:S152-S153.
Tokudome G., Tomonari H., Gardner J.P., Aladjem M., Fine B.P., Lasker N., Gutkin M., Byrd L.H., Aviv A. (1990) Variations in the apparent pH set point for activation of platelet Na-H antiport. Hypertension 16:180-189.
Battle D.C., Saleh A., Rombola G. (1990) Reduced intracellular pH in lymphocytes from the spontaneously hypertensive rat. Hypertension 15:97-103.
Resnick L.M., Gupta R.K., Bhargava K.K., Laragh J.H. (1990) RBC cytosolic free calcium levels in hypertension: Relation to blood pressure and other cations. Am J Hypertens. , part 2, abstract; 3:59a.
Aviv A., Livne A. (1988) The Na/H antiport, cytosolic free Ca, and essential hypertension: A hypothesis. Am. J. Hypertension 1:410-413.
Lenz T., Haller H., Ludersdorf M., Kribben A., Thiede M., Distler A., Philipp T. (1985) Free intracellular calcium in essential hypertension. Effects of nifedipine and captopril. J. Hypertension 3:S13-S15.
Cole C.H. (1973) Decreased ouabain sensitive adenosine triphosphatase activity in the erythrocyte membrane of patients with chronic renal disease. Clin. Sci. Mol. Med. 45:775-784.
Deepak K., Khan T. (1987) Na-K pump in chronic renal failure. Am. J. Physiol. 252:F785-F793.
Labonia W.D., Morelli O.H., Gimenez M.I., Freuler P.V., Morelli O.H. (1987) Effects of L-carnitine on sodium transport in erythrocytes from dialyzed uremic patients. Kidney Int. 32:754-759.
Krzesinski J.M., Rorive G.L. (1988) Influence of sodium balance on uremic red blood cell ion transport. Nephron 49:126-131.
Moosa A., Greaves M., Brown C.B., Mac Neil S. (1990) Elevated platelet free calcium in uremia. Br. J. Haematol. 74:300-305.
Schiffl H. (1990) Correlation of blood pressure in end-stage renal disease with platelet cytosolic free calcium concentration. Klin. Wochenschr. 68:718-722.
Fervenza F.C., Hendry B.M., Ellory J.C. (1989) Effects of dialysis and transplantation on red blood cell Na pump function in renal failure. Nephron 53:121-128.
Nieman L.K., Davis F.B., Davies P.J., Cunningham E.E., Gutman S., Blas S.D., Schoenl M. (1983) Effect of end-stage renal disease on responsiveness to calmodulin and thyroid hormone of calcium-ATPase in human red blood cells. Kidney Int. 24:S167-S170.
Ware J.A., Clark B.A., Smith M., Salzman E.W. (1989) Abnormalities of cytoplasmic Ca in platelets from patients with uremia. Blood 73:172-176.
Izumo H., Izumo S., Deluise M., Flier J.S. (1984) Erythrocyte Na,K pump in uremia. Acute correction of a transport defect by hemodialysis. J. Clin. Invest. 74:581-588.
Monti J.P., Gallice P., Baz M., Murisasco A., Crevat A., Elsen R. (1989) Intraerythrocytic pH variations during hemodialysis: A P31 NMR study. Kidney Int. 35:871-874.
Rombola G., Colussi G., Guastoni C., Teatini V., Perogo A., Perrino L., Benazzi E., Civati G., Minetti I. (1990) Intracellular pH variations during high surface acetate dialysis treatment Nephrol. Dial. Transplant , abstract; 5:712.
Similar publications
Sorry the service is unavailable at the moment. Please try again later.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.